National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA01	COZAAR	B	Losartan potassium - 50mg	50mg	Tablet	1,420,634 L.L
G04BE08	CIALIS	B	Tadalafil - 5mg	5mg	Tablet, film coated	6,512,261 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 36mg	36mg	Tablet, extended release	4,393,021 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 54mg	54mg	Tablet, extended release	6,049,979 L.L
N06BA04	CONCERTA	B	Methylphenidate HCl - 18mg	18mg	Tablet, extended release	3,133,841 L.L
N02BE01	CHILDREN'S PANADOL 5-12 YEARS	B	Paracetamol - 240mg/5ml	240mg/5ml	Elixir	356,118 L.L
C09CA01	COZAAR	B	Losartan potassium - 100mg	100mg	Tablet	1,740,596 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 20mg	20mg	Tablet, film coated	401,478,618 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 40mg	40mg	Tablet, film coated	401,478,618 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 60mg	60mg	Tablet, film coated	401,478,618 L.L
L01DB01	CAELYX	B	Doxorubicin HCl pegylated liposomes - 20mg/10ml	20mg/10ml	Injectable concentrated solution	L.L
S01ED51	COMBIGAN 2mg/ml 5mg/ml	B	Timolol - 5mg/ml, Brimonidine tartrate - 2mg/ml		Drops solution	1,181,238 L.L
S01ED51	COMBIGAN 2mg/ml 5mg/ml	B	Timolol - 5mg/ml, Brimonidine tartrate - 2mg/ml		Drops solution	1,181,238 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 250mg/5ml	250mg/5ml	Granules for suspension	851,100 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 750mg	750mg	Tablet, film coated, modified release	1,555,018 L.L
C10AA07	CRESTOR	B	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	804,962 L.L
J01DC04	CECLOR	B	Cefaclor (monohydrate) - 125mg/5ml	125mg/5ml	Granules for suspension	487,623 L.L
L04AA18	CERTICAN	B	Everolimus - 0.5mg	0.5mg	Tablet	L.L
L04AA18	CERTICAN	B	Everolimus - 0.75mg	0.75mg	Tablet	L.L

National Cancer Registry (NCR)